https://biotechmorning.com/news/gene-editing-child-deaths-china-oversight Biotech Morning en 2026-09-28T14:14:05.410Z Gene Editing's Darkest Day: Two Children Dead, and China Stayed Quiet https://biotechmorning.com/news/telix-itm-isotope-acquisition-radiopharmaceutical-supply Biotech Morning en 2026-09-28T14:13:28.924Z Telix Just Spent $2.35 Billion to Own the Fuel Behind Cancer's Hottest Weapons https://biotechmorning.com/news/prime-medicine-prime-editing-aatd-ind-clearance Biotech Morning en 2026-09-28T14:12:40.217Z The Gene Editor That Rewrites Your DNA Like a Word Processor https://biotechmorning.com/news/gotistobart-nearly-doubles-survival-squamous-nsclc Biotech Morning en 2026-09-28T14:11:46.856Z The Lung Cancer Drug That Nearly Doubled Survival Time https://biotechmorning.com/news/roche-simcere-zaiming-trispecific-antibody-deal Biotech Morning en 2026-09-28T14:11:03.790Z Roche Just Bet $1.5B on a Drug That Hasn't Touched a Human Yet https://biotechmorning.com/news/brelovitug-hepatitis-delta-phase-3-azure Biotech Morning en 2026-09-28T14:10:16.187Z The Liver Disease Nobody Talks About Just Got a New Weapon https://biotechmorning.com/news/eli-lilly-once-weekly-insulin-approval Biotech Morning en 2026-09-28T14:09:31.960Z The End of 300 Needles a Year https://biotechmorning.com/news/cancer-therapy-curing-lupus-adicet-car-t Biotech Morning en 2026-09-28T14:08:52.264Z The Cancer Therapy That's Curing Lupus https://biotechmorning.com/news/astrazeneca-wainua-attr-cm-phase-3-failure Biotech Morning en 2026-09-28T14:08:05.079Z AstraZeneca's Billion-Dollar Heart Drug Just Hit a Wall Nobody Saw Coming https://biotechmorning.com/news/trump-rescission-billion-biotech-pipeline Biotech Morning en 2026-09-27T14:18:05.603Z The $1 Billion Disappearing Act That Could Starve Biotech's Pipeline https://biotechmorning.com/news/in-vivo-car-t-iaso-bio-first-human-data Biotech Morning en 2026-09-27T14:17:25.796Z What If Your Body Could Build Its Own Cancer Therapy? https://biotechmorning.com/news/lilly-innocare-3-billion-china-licensing-deal Biotech Morning en 2026-09-27T14:16:34.525Z Lilly Just Bet $3.35 Billion on a Chinese Biotech You've Never Heard Of https://biotechmorning.com/news/sarepta-elevidys-black-box-warning-deaths Biotech Morning en 2026-09-27T14:15:37.077Z Sarepta's Gene Therapy Was Supposed to Change Everything. Then Kids Started Dying. https://biotechmorning.com/news/lundbeck-ditches-midwest-for-boston Biotech Morning en 2026-09-27T14:14:48.677Z Why Lundbeck Just Ditched the Midwest for Boston's Brain Belt https://biotechmorning.com/news/roche-magl-inhibitor-progressive-ms Biotech Morning en 2026-09-27T14:14:03.685Z Roche's Unusual Bet on a Lipid Enzyme Could Crack Progressive MS Wide Open https://biotechmorning.com/news/lilly-breast-cancer-combo-approval Biotech Morning en 2026-09-27T14:13:19.176Z Lilly's Secret Weapon in Breast Cancer Isn't What You Think https://biotechmorning.com/news/revolution-medicines-ras-pancreatic-cancer-drug Biotech Morning en 2026-09-27T14:12:32.459Z The Cancer Gene Nobody Could Drug (Until Now) https://biotechmorning.com/news/novo-nordisk-orbis-macrocycle-oral-deal Biotech Morning en 2026-09-27T14:11:45.970Z Novo Nordisk Really Wants You to Swallow a $1.4B Pill https://biotechmorning.com/news/lilly-2-9-billion-merida-biosciences-acquisition-2 Biotech Morning en 2026-09-27T14:11:00.379Z Lilly Just Dropped $2.9 Billion on a Company You've Never Heard Of